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Editorial on the Research Topic
Imaging in Acute Stroke—New Options and State of the Art
During the last two decades, the state of art imaging in acute stroke has developed from non-contrast 
CT performed within 7  days to including hyperacute imaging including both angiographic and 
perfusion imaging. This includes using both new techniques but also using new ways to combine 
long existing modalities in daily practice. The increasing focus on the importance of both swift and 
reliable diagnostics combined with an improved scanner accessibility has fueled this development.
This development in imaging has answered to the needs of the introduction of acute vascular 
recanalization treatments in ischemic stroke, which has revolutionized the area. I.V. thrombolysis 
has been increasingly used since the end of the 1990s and is now considered a standard treatment, 
while mechanical thrombectomy has been accepted as a standard procedure following randomized 
controlled trials documenting its efficacy within the last 5  years. Further, efficacious treatment 
options in acute ICH are sought, including thrombostatics to reduce final hematoma volume lead-
ing to increased activity in this area also.
The imaging modalities, which are in widespread use in primary stroke imaging—at least in 
tertiary centers, include CT, MRI, and sonography. These methods are complementary in clinical 
practice with their different strengths. In the following, we will discuss generally available methods 
to image brain parenchyma, cerebral, and pre-cerebral vasculature and cerebral perfusion in acute 
stroke.
iMaGiNG tHE BraiN ParENCHYMa
Time is of the essence in the diagnosis and treatment of acute ischemic stroke (1). It has been shown 
that by using a CT-based set-up for IV thrombolysis, a door to needle time around 20 min is achiev-
able based on admitting patients directly to hospital units providing imaging facilities including 
radiology department, emergency rooms, or trauma centers (2).
CT has a high sensitivity in detecting blood and thereby identifying a bleeding in the brain 
parenchyma, which is the major contraindication in IV thrombolysis as well as identifying, 
e.g., neoplasms. Consequently, IV thrombolysis can be initiated safely based on a non-contrast-CT 
of the brain as only brain imaging (3).
It has been reported that dual-energy CT (DECT-CT) should improve detection of underly-
ing causes for ICH as well as the differentiation between blood and leaked iodine contrast after 
endovascular procedures compared to standard non-contrast CT.
Trans cranial Doppler (TCD) has little use in visualizing brain parenchyma but can be used to 
measure the size of an intracerebral hemorrhage and thus visualize an eventual expansion in size (4); 
2Christensen and Christensen Imaging in Acute Stroke
Frontiers in Neurology | www.frontiersin.org January 2018 | Volume 8 | Article 736
however, the sensitivity for, e.g., hemorrhage in proximity to the 
scull base does not allow for this modality as only imaging before 
revascularisation treatment.
MRI is superior to CT in showing acute ischemic changes in 
the brain parenchyma (5). Diffusion-weighted imaging shows 
the ischemic lesion in 80–90% of cases in acute stroke but, 
in the remaining patients, there will not be DWI-positivity, 
i.e., the DWI-negative stroke (6). Consequently, a reliable diagno-
sis of stroke cannot be made based on only MRI conformation if 
ischemia, clinical diagnosis is still needed.
The ability to detect ischemic lesions is, however, also valuable 
in transient ischemic attack (TIA). This diagnosis is in Europe 
based on clinical definitions, but severity scores are used in com-
bination with DWI-positivity in the identification of high-risk 
patients who have a substantial risk of a subsequently ischemic 
stroke (7). An unexplained sevenfold variation exists in the fre-
quency of DWI lesions between TIA cohorts, and a DWI-negative 
scan is very far from ruling out a true ischemic event in these 
patients (8). MRI is also superior in identifying the underlying 
cause of stroke based on examination of the brain parenchyma: 
the pattern of DWI lesions helps to differentiate between large 
vessel disease and cardiac emboli where, in the latter, several 
vascular territories are often affected. Microvascular changes in 
small vessel disease can be diagnosed and quantified, not only 
forming the basis of a diagnosis of small vessel disease but also in 
differencing between probable cerebral amyloid angiopathy and 
deep perforator angiopathy. MRI allows for identifying location 
and number of micro bleeds, lacunar infarcts, unspecific vascular 
gliosis, and enhanced perivascular space.
Substantial leukoariosis predict a higher risk of both symp-
tomatic and asymptomatic hemorrhage after IV thrombolysis 
treatment and independent of this was evaluated by MRI or CT 
(9). The presence of cerebral micro-bleeds before IV thrombolysis 
treatment predicts and increased risk of new micro-bleeds after 
treatment. Further, patients with new micro-bleeds were more 
likely to develop symptomatic remote hemorrhage, but no 
increase in rate of hemorrhagic transformation was observed, 
consequently, this is of minor clinical importance (10).
Using MRI in the work-up of hyperacute stroke increases the 
door to needle time with about 10 min even in a well-organized 
setting. This is due to MRI safety issues as well as longer scan-
time compared to CT (11). A protocol used for evaluating acute 
ischemia must include T2 flair and a hemo-sequence in order to 
exclude intracerebral bleeding. MRI is not possible in a substan-
tial number of acute stroke patients due to either safety issues, 
being unable to cooperate, or in need of close monitoring. The 
number of patients falling into this category has been reported 
as high as 20–40% (12) MRI is performed without applying any 
radiation to the patient in comparison with CT, which makes it 
safer to use regarding younger patients.
iMaGiNG tHE artErial VESSElS oF 
tHE HEad aNd NECK
By adding CT-angiography (CTA) to an nc-CT, the vessels from 
the aortic arch to the vertex can be visualized with a resolution 
of 0.5  mm iso voxel corresponding to a vessel size of 1  mm. 
This reveals vessel occlusion down to vessel sized too small 
for mechanical thrombectomy, thereby allowing for precise 
identification of patients for this procedure. CTA is also reliable 
in evaluation for underlying pathologies such as dissection and 
arteriosclerotic disease (13, 14).
CT-angiography in combination with cerebral post-contrast 
CT is not only a strong tool in identification of neoplasms but also 
other underlying causes in patients with intracerebral hemor-
rhage, including some vascular malformations (15). In addition, 
the presence of arterial and/or venous extravasation of contrast, 
the so-called spot-sign, is a strong predictor for hematoma 
expansion with resulting poorer outcome (16). This may be of 
use in selecting patients for experimental treatment with pro-
thrombotic drugs in order to reduce hematoma expansion (16).
Dual-energy CT improves the diagnostic accuracy of CTA 
in areas close to bone (17), which is clinically highly relevant in 
patients with posterior circulation stroke.
Sonography can be performed in the stroke unit and, since it 
involves no radiation exposure, patient safety issues will not limit 
the number of examinations. It is possible to evaluate both arte-
rial vessels of the neck as well as intracranial vessels—the latter 
only as a flow examination whereas the vessel wall of the arteries 
of the neck can be examined with a resolution of 0.2 mm. This 
allows the detection of occlusions and stenosis as by CTA but 
with a greater possibility of a non-conclusive examination based 
on the possible lack of a temporal sonar window or other bone 
disturbances of the sonar signal. TCD allows for documentation 
of reperfusion after IV thrombolysis treatment (18) as well as for 
quantification of collateral status in middle cerebral artery occlu-
sion by measuring the flow in the anterior cerebral arteries (19). 
This allows for close observation of this critical patient group.
Sonography has the ability to verify vessel wall changes in 
cervical arteries including dissection, plaque characterization, 
and detection of unstable thrombi; however, the clinical impli-
cations of especially plaque characterization remain uncertain. 
Likewise, it is standard practice to use Duplex in the preop-
erative evaluation of carotid stenosis for thrombentaretectomy 
using flow measurements to quantify the degree of a stenosis 
even if CTA has documented a reduction in vessel lumen (20). 
By using ultrasound contrast media, it is possible to diagnose 
the presence of persistent foramen ovale or a pulmonary fistula 
if contrast media is detected in the intracerebral circulation after 
Valsalva (21).
Further, continuous sonographic input on the acute thrombo-
sis increases the thrombolytic effects of rTPA (22).
MR angiography may be performed without contrast as Time 
of Flight sequences, i.e., arterial TOF, which is more time con-
suming compared to CT angiography as the scan time is several 
minutes just to visualize the intracranial arteries and longer if the 
cervical arteries are also included. The longer the scan time the 
higher the risk of impairing movement artifacts, which are more 
prevalent in MRi in an acute setting in comparison to planned 
examinations (Havsteen et al.).
Contrast-enhanced arterial TOF-sequences improve detec-
tion of pathology in the vessel lumen in comparison to non-
contrast-enhanced TOF sequences. Contrast-enhanced TOF 
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can be augmented to a resolution down to 0.5 mm isovoxel—the 
same level as CTA—when using 3-T MRi, but at the expense of 
prolonged scan time.
Comparative studies show no difference in the sensitivity 
for detection small aneurisms in comparison to CTA, but the 
specificity seems to be lower (23). High resolution MRi (HR-MRi) 
can characterize arteriosclerotic plaques often using contrast-
enhanced series, which is reported to give prognostic informa-
tion about the risk of subsequent vascular events. HR-MRi can 
also verify dissection changes in small intracranial arteries and 
visualize reperfusion of such vessels. Vessel wall imaging may be 
improved by using higher field strength, i.e., 7T MRI (24).
CT-perfusion can be added to the imaging protocol at the 
price of 5  min more scan-time and an extra 3–5  ms radiation 
dose. Whole-brain CT-perfusion, i.e., 16 cm coverage has been 
introduced and has the ability to show areas with low perfusion 
anywhere in the brain and not restricted to a 4–8 cm slab. This can 
be useful to both quantify the area with perfusion below which 
brain parenchyma is lost, i.e., infarct core as well as surround-
ing salvageable areas with less degree of decreased perfusion, 
i.e., penumbra. Recently, results from the DAWN study (25) 
were presented at the ESOC 2017 conference indicating that 
CT-perfusion—or MR-DWI—can be used to select patients for 
thrombectomy up to 24 h after ictus, increasing the clinical inter-
est in CTP. The DAWN study was set up to address the issue of 
wake up and late presenting strokes and neurointervention based 
on CT-perfusion or DWI-FLAIR mismatch: imaging markers 
of salvageable tissue. In order to differentiate between ischemic 
stroke and stroke mimics, perfusion CT may also be helpful and 
thus compensate for the low visibility of acute ischemia in the 
brain parenchyma on non-contrast CT alone (26).
An additional feature of whole brain perfusion is the pos-
sibility to extract a 4-D angiogram from the perfusion image 
data without having to perform an angiography; these images 
show the filling of the intracranial vessels from the early arterial 
to the late venous phase, which adds a dynamic perspective in 
the evaluation of acute ischemia improving the visualization of 
collateral filling (27). The lack of visualization of the vessels of 
the neck using this method alone can hinder the diagnosis of the 
underlying cause of stroke.
MRI perfusion is able to show the same findings as CT-perfusion 
and when it is based on the use of contrast MRI perfusion has 
considerable advantages especially in obtaining absolute meas-
ures of perfusion. It is also possible to apply perfusion sequences 
without the use of contrast, i.e., arterial spin labeling techniques 
ASL. ASL has proven as reliable as contrast-enhanced perfusion 
techniques in detecting areas with reduced perfusion in acute 
brain ischemia (28) and with the more extensive use of 3T MRi 
technology, the resolution has improved. It is reported that add-
ing ASL to a DWI-based TIA protocol increases correct detection 
of ischemic lesions by 5%. This is primarily the case when the 
DWI lesion is very small and, therefore, doubtful but with a 
simultaneous area of hypo perfusion surrounding it clarifying 
the ischemic diagnosis (29).
Perfusion MRI, in combination with DWI, may also guide the 
decision of mechanical thrombectomy in large vessel occlusion 
with unknown time of onset based on the mismatch of the infarct 
core and the surrounding penumbra on CT perfusion (29), but 
is more time-consuming than the approach used in the DAWN 
study.
CoNClUSioN
Combining several image techniques offers several opportunities 
and advantages. Modern ultrasound apparatus thus offers real-
time image fusion so that sonography of the intracranial vessels 
can be performed using an already performed CTA as anatomi-
cal guide. The CTA images can be viewed simultaneously with 
the live images from TCD and thus assist in the evaluation of 
intracranial stenosis. Likewise, it is possible in a modern PACS 
system to co-evaluate all three modalities and thus extract the 
needed information. This can combine information from a MRI 
perfusion investigation with CTA visualization of the vessel 
and Doppler measurements in order to assess the impact of 
the changes. The information of flow direction and speed form 
sonography in combination with perfusion measurements and 
images of the vessel wall can help to explain the extent and loca-
tion of ischemic lesions and help to decide the treatment options. 
In acute stroke, the access to all these modalities help to ensure 
the correct action needed; however, this requires a neuroradiolo-
gist on call in collaboration with specialized stroke neurologists. 
Often in our experience from a tertiary centre, a good strategy is 
to combine a CTA with an MRI of the brain (DWI, FLAIR, GE/
SWI, ASL) to diagnose the cause of stroke and to rule out stroke 
mimics.
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